Note*: This report requires 5-10 business days to complete.
DelveInsight’s Human Papillomavirus (HPV) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Human Papillomavirus (HPV) forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Human Papillomavirus (HPV) till 2023.
Key Coverage and Benefits
• The report will help in developing business strategies by understanding the trends shaping and driving the global Human Papillomavirus (HPV) market.
• Identifying patient populations in the global “Human Papillomavirus (HPV)market to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the best opportunities for Human Papillomavirus (HPV) therapeutics in each of the markets covered.
• To understand the future market competition in the global Human Papillomavirus (HPV) therapeutics market and Insightful review of the key market drivers and barriers.
Scope
• Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
• Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
• The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.
• It also provides Human Papillomavirus (HPV) for United States, EU5 and Japan from 2013 and forecasted Market to 2023.
'
Table of Contents
• Human Papillomavirus (HPV) overview
• Pathophysiology
• Symptoms of disease
• Etiology of disease
• Diagnosis of disease
• Treatment of disease
• Overview of Marketed drugs
• Drug Description
• Mechanism of Action
• Pharmacokinetics Properties
• Marketed Details
• Patent Information
• Patent Exclusivity Expiry Assessment United States (US)
• Patents Details
• Historical and Forecasted sales of marketed molecules in the Global Human Papillomavirus (HPV) Market
• Global Epidemiology of Human Papillomavirus (HPV) Forecasted to 2023
• Global Market (2013-2015)
• Global Forecasted Market (2016-2023)
• Global Market by Geography
• Market of US (2013-2015)
• Forecasted Market of US (2016-2023)
• Market of Europe
• Market of Germany (2013-2015)
• Forecasted Market of Germany (2016-2023)
• Market of United Kingdom (2013-2015)
• Forecasted Market of United Kingdom (2016-2023)
• Market of France (2013-2015)
• Forecasted Market of France (2016-2023)
• Market of Italy (2013-2015)
• Forecasted Market of Italy (2016-2023)
• Market of Spain (2013-2015)
• Forecasted Market of Spain (2016-2023)
• Market of Japan (2013-2015)
• Forecasted Market of Japan (2016-2023)
• Market of ROW (2013-2015)
• Forecasted Market of ROW (2016-2023)
• Appendix
• Report Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight
List of Tables
• Table 1: Drug Description
• Table 2: Drug, Marketed Details United States (US)
• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
• Table 4: Drug, Patent Details for US
• Table 5: Human Papillomavirus (HPV) Drug Sales (USD Millions)-2023
• Table 6: Global Epidemiology of Human Papillomavirus (HPV) (2013-2023)
• Table 7: Human Papillomavirus (HPV) Global Market (USD Millions), (2013-2015)
• Table 8: Human Papillomavirus (HPV) Global Market (USD Millions), (2016-2023)
• Table 9: Human Papillomavirus (HPV) US Market (USD Millions), (2013-2015)
• Table 10: Human Papillomavirus (HPV) US Market (USD Millions), (2016-2023)
• Table 11: Human Papillomavirus (HPV) Germany Market (USD Millions), (2013-2015)
• Table 12: Human Papillomavirus (HPV) Germany Market (USD Millions), (2016-2023)
• Table 13: Human Papillomavirus (HPV) United Kingdom Market (USD Millions), (2013-2015)
• Table 14: Human Papillomavirus (HPV) United Kingdom Market (USD Millions), (2016-2023)
• Table 15: Human Papillomavirus (HPV) France Market (USD Millions), (2013-2015)
• Table 16: Human Papillomavirus (HPV) France Market (USD Millions), (2016-2023)
• Table 17: Human Papillomavirus (HPV) Italy Market (USD Millions), (2013-2015)
• Table 18: Human Papillomavirus (HPV) Italy Market (USD Millions), (2016-2023)
• Table 19: Human Papillomavirus (HPV) Spain Market (USD Millions), (2013-2015)
• Table 20: Human Papillomavirus (HPV) Spain Market (USD Millions), (2016-2023)
• Table 21: Human Papillomavirus (HPV) Japan Market (USD Millions), (2013-2015)
• Table 22: Human Papillomavirus (HPV) Japan Market (USD Millions), (2016-2023)
• Table 23: Human Papillomavirus (HPV) ROW Market (USD Millions), (2013-2015)
• Table 24: Human Papillomavirus (HPV) ROW Market (USD Millions), (2016-2023)
List of Figures
• Figure 1: Human Papillomavirus (HPV) Drug Sales (USD Millions)-2023
• Figure 2: Global Epidemiology of Human Papillomavirus (HPV) (2013-2023)
• Figure 3: Human Papillomavirus (HPV) Global Market (USD Millions), (2013-2015)
• Figure 4: Human Papillomavirus (HPV) Global Market (USD Millions), (2016-2023)
• Figure 5: Human Papillomavirus (HPV) US Market (USD Millions), (2013-2015)
• Figure 6: Human Papillomavirus (HPV) US Market (USD Millions), (2016-2023)
• Figure 7: Human Papillomavirus (HPV) Germany Market (USD Millions), (2013-2015)
• Figure 8: Human Papillomavirus (HPV) Germany Market (USD Millions), (2016-2023)
• Figure 9: Human Papillomavirus (HPV) United Kingdom Market (USD Millions), (2013-2015)
• Figure 10: Human Papillomavirus (HPV) United Kingdom Market (USD Millions), (2016-2023)
• Figure 11: Human Papillomavirus (HPV) France Market (USD Millions), (2013-2015)
• Figure 12: Human Papillomavirus (HPV) France Market (USD Millions), (2016-2023)
• Figure 13: Human Papillomavirus (HPV) Italy Market (USD Millions), (2013-2015)
• Figure 14: Human Papillomavirus (HPV) Italy Market (USD Millions), (2016-2023)
• Figure 15: Human Papillomavirus (HPV) Spain Market (USD Millions), (2013-2015)
• Figure 16: Human Papillomavirus (HPV) Spain Market (USD Millions), (2016-2023)
• Figure 17: Human Papillomavirus (HPV) Japan Market (USD Millions), (2013-2015)
• Figure 18: Human Papillomavirus (HPV) Japan Market (USD Millions), (2015-2023)
• Figure 19: Human Papillomavirus (HPV) ROW Market (USD Millions), (2013-2015)
• Figure 20: Human Papillomavirus (HPV) ROW Market (USD Millions), (2016-2023)
• Immunovaccine Inc.
• Inovio Pharmaceuticals Inc.
• Karyopharm Therapeutics Inc.
• Kite Pharma Inc.
• MedImmune LLC
• Novartis AG
• Onconova Therapeutics Inc.
• Shantha Biotechnics Limited
• Sirnaomics Inc.
• Theravectys SA
• Transgene SA
• UbiVac LLC
• Virometix AG
